Abstract:Abstract Sepsis is defined as life-threatening organ dysfunction caused by dysregulated host systemic inflammatory and immune response to infection. Over decades, advanced understanding of host–microorganism interaction has gradually unmasked the genuine nature of sepsis, guiding toward new definition and novel therapeutic approaches. Diverse clinical manifestations and outcomes among infectious patients have suggested the heterogeneity of immunopathology, while systemic inflammatory responses and deteriorating organ function observed in critically ill patients imply the extensively hyperactivated cascades by the host defense system. From focusing on microorganism pathogenicity, research interests have turned toward the molecular basis of host responses. Though progress has been made regarding recognition and management of clinical sepsis, incidence and mortality rate remain high. Furthermore, clinical trials of therapeutics have failed to obtain promising results. As far as we know, there was no systematic review addressing sepsis-related molecular signaling pathways and intervention therapy in literature. Increasing studies have succeeded to confirm novel functions of involved signaling pathways and comment on efficacy of intervention therapies amid sepsis. However, few of these studies attempt to elucidate the underlining mechanism in progression of sepsis, while other failed to integrate preliminary findings and describe in a broader view. This review focuses on the important signaling pathways, potential molecular mechanism, and pathway-associated therapy in sepsis. Host-derived molecules interacting with activated cells possess pivotal role for sepsis pathogenesis by dynamic regulation of signaling pathways. Cross-talk and functions of these molecules are also discussed in detail. Lastly, potential novel therapeutic strategies precisely targeting on signaling pathways and molecules are mentioned.

The role of ubiquitination in microbial infection induced endothelial dysfunction: potential therapeutic targets for sepsis

Endothelial Cell Dysfunction and Targeted Therapeutic Drugs in Sepsis

The Emerging Role of Adaptor Proteins in Regulating Innate Immunity of Sepsis

Ubiquitination in pyroptosis pathway: A potential therapeutic target for sepsis

The pathogenesis and potential therapeutic targets in sepsis

Endothelial dysfunction: a therapeutic target in bacterial sepsis?

From immune dysregulation to organ dysfunction: understanding the enigma of Sepsis

Molecular basis of endothelial dysfunction in sepsis

Nanoplatforms for Sepsis Management: Rapid Detection/Warning, Pathogen Elimination and Restoring Immune Homeostasis

Molecular Pathways in Sepsis Pathogenesis: Recent Advances and Therapeutic Avenues

The significance and regulatory mechanisms of innate immune cells in the development of sepsis.

Defensins and Sepsis

Signaling pathways and intervention therapies in sepsis

Defensins and sepsis.

The effects of sepsis on endothelium and clinical implications

The Significance and Regulatory Mechanisms of Innate Immune Cells in the Development of Sepsis

Role of sirtuins in sepsis and sepsis-induced organ dysfunction: A review

The dysfunction of complement and coagulation in diseases: the implications for the therapeutic interventions

Endothelial Cell Dysfunction Due to Molecules Secreted by Macrophages in Sepsis

Post-translational modifications in sepsis-induced organ dysfunction: mechanisms and implications

Effect of endothelial responses on sepsis-associated organ dysfunction